ULLIAN ELAINE

Insider Buys Quantity –
5
2017-11-13SaleHologic, Inc.
HOLX
director
18,564
0.0049%
$29.66$550,608-2.23%
2017-08-03SaleHologic, Inc.
HOLX
director
13,804
0.0045%
$36.47$503,397-2.58%
2017-07-03SaleHologic, Inc.
HOLX
director
17,698
0.0055%
$39.05$691,054-13.08%
2017-06-02SaleHologic, Inc.
HOLX
director
17,876
0.0054%
$38.40$686,483-13.46%
2017-05-03SaleHologic, Inc.
HOLX
director
17,712
0.0054%
$38.95$689,927-12.21%
2017-04-03SaleHologic, Inc.
HOLX
director
18,208
0.0057%
$37.61$684,757-3.04%
2017-03-03SaleHologic, Inc.
HOLX
director
18,512
0.0059%
$36.82$681,566+2.96%
2017-02-03SaleHologic, Inc.
HOLX
director
18,846
0.0061%
$36.18$681,801+7.28%
2017-01-03SaleHologic, Inc.
HOLX
director
18,702
0.0061%
$36.41$680,893+2.96%
2016-10-10SaleHologic, Inc.
HOLX
director
36,472
0.0119%
$36.35$1.33M+0.3%
2016-05-26SaleHologic, Inc.
HOLX
director
13,792
0.005%
$33.85$466,859+15.18%
2015-12-01SaleVertex Pharmaceuticals Incorporated
VRTX
director
22,500
0.0093%
$129.72$2.92M-31.64%
2015-11-02SaleVertex Pharmaceuticals Incorporated
VRTX
director
20,000
0.0082%
$126.33$2.53M-28.8%
2015-10-02SaleVertex Pharmaceuticals Incorporated
VRTX
director
20,000
0.0079%
$110.00$2.2M-19.67%
2015-01-02SaleVertex Pharmaceuticals Incorporated
VRTX
director
10,000
0.0042%
$122.62$1.23M+1.36%
2014-10-01SaleVertex Pharmaceuticals Incorporated
VRTX
director
10,000
0.0042%
$107.74$1.08M+14.83%
2014-09-09PurchaseHologic, Inc.
HOLX
director
15,800
0.0058%
$25.36$400,688+28.03%
2014-07-01SaleVertex Pharmaceuticals Incorporated
VRTX
director
5,000
0.0021%
$95.21$476,066+22.1%
2014-06-09SaleVertex Pharmaceuticals Incorporated
VRTX
director
2,500
0.0011%
$75.00$187,500+52.4%
2014-05-06SaleHologic, Inc.
HOLX
director
19,890
0.0056%
$18.34$364,683+10.46%